Cmi Cardiologie-Dr. Mercea Corina Delia
- Address
- Bd. Independentei 10/43 Punct de lucru:Strada Petre Dulfu nr.12A,Spatiu Comercial nr.1 Tronson Vest, 430124 Baia Mare, Romania
Cardiovascular Disease Research
The site focuses on primary prevention of atherosclerotic cardiovascular disease and related lipid disorders, aiming to test new therapies that lower major adverse cardiac events.
- inclisiran trial assessing reduction of 4P-MACE
- LY3819469 study targeting lipoprotein(a) reduction
- evaluation of novel lipid‑lowering strategies
Research at Cmi Cardiologie-Dr. Mercea Corina Delia supports advances in heart health for high‑risk patients.
Metabolic and Nutritional Research
Studies address obesity and overweight along with associated metabolic risk, exploring treatments that improve weight management and overall metabolic outcomes.
- tirzepatide trial measuring morbidity and mortality in adults with obesity
- investigations into nutritional interventions for metabolic disease
- assessment of weight‑loss efficacy and safety
The Baia Mare clinic integrates cardiovascular and metabolic insights to enhance patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cmi Cardiologie-Dr. Mercea Corina Delia
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Inclisiran in Reducing Major Adverse Cardiovascular Events in High-Risk Primary Prevention of Atherosclerotic Cardiovascular Disease | Novartis Pharma AG | Phase III | Not Recruiting | Sep 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 2 | Unknown | 2023-09-04 | 2023-09-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.